BRF2 and invasive breast carcinoma: The data detailed in Fig. 6a-c, prompted an examination of overall survival for patients with breast invasive carcinoma with concurrent alterations in BRF2 and breast cancer biomarkers which were determined to be either co-occurring or mutually exclusive and statistically significant, Fig. 6c.